Louis Garguilo, Chief Editor, Outsourced Pharma, has published the latest part of his interview with Ali Pashazadeh, CEO, Treehill where Ali details why we think biopharmas and outsourced providers need strategic help to focus more on profitability.
Our view is that players need help with a consultative, holistic view of development and commercialization. Sponsors often tread thin on obtaining and incorporating important advice when forming development and manufacturing plans with their outsourcing partners, regarding the viability of targeting certain molecules to treat specific diseases.
Louis asks his readers: “Do you hold back strategic plans from your development and manufacturing contractors? Do you ask them to offer more strategic (life-cycle) insights?“
Read the full article on Outsourced Pharma (07-Jun 2024):
https://www.outsourcedpharma.com/doc/drug-development-needs-more-focus-on-profitability-0001